Leishmania tarentolae novel responses to Bi(3+)-doped strontium aluminum oxyfluorides

Novel therapeutics for the treatment of leishmaniasis are of interest as the disease not only is becoming more prevalent, but drug resistance is increasing in certain regions of the world. Reported here is the use of Bi(3+)-doped strontium aluminum oxyfluoride phosphors and protease inhibitors to te...

Descripción completa

Detalles Bibliográficos
Autores principales: Apuzzo, C. Fiore, Sullivan, Eirin C., Platt, David C., Seger-Held, Ian, Jones, Marjorie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414179/
https://www.ncbi.nlm.nih.gov/pubmed/34504976
http://dx.doi.org/10.1016/j.heliyon.2021.e07896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414179/
https://www.ncbi.nlm.nih.gov/pubmed/34504976
http://dx.doi.org/10.1016/j.heliyon.2021.e07896

Ejemplares similares